As of 2025-10-15, the Intrinsic Value of Replimune Group Inc (REPL) is -17.95 USD. This REPL valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.74 USD, the upside of Replimune Group Inc is -478.67%.
Based on its market price of 4.74 USD and our intrinsic valuation, Replimune Group Inc (REPL) is overvalued by 478.67%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.95 - -17.95 | -17.95 | -478.67% |
| P/E | (114.01) - (125.21) | (114.33) | -2512.1% |
| DDM - Stable | (28.04) - (78.44) | (53.24) | -1223.1% |
| DDM - Multi | (21.69) - (48.08) | (29.99) | -732.8% |
| Market Cap (mil) | 370.00 |
| Beta | -0.07 |
| Outstanding shares (mil) | 78.06 |
| Enterprise Value (mil) | 344.79 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.54% |
| Cost of Debt | 5.00% |
| WACC | 9.60% |